SCHEMBL7550302

SCHEMBL7550302

CN1CCN(CCCn2cc(-c3cncc(-c4ccsc4)c3)c3cc(Cl)ccc32)CC1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 10/20 0.78
FLT1 P17948 5/20 0.78
FLT4 P35916 5/20 0.78
GSK3B P49841 2/20 0.41
NFATC1 O95644 1/20 0.41
DYRK1A Q13627 1/20 0.41
CYP2A6 P11509 2/20 0.39
HTR7 P34969 1/20 0.38
DRD2 P14416 3/20 0.37
DRD3 P35462 3/20 0.37
SLC22A1 O15245 1/20 0.36
ABCB11 O95342 1/20 0.36
LMNA P02545 1/20 0.36
TP53 P04637 1/20 0.36
CYP1A2 P05177 1/20 0.36
FYN P06241 1/20 0.36
CHRM2 P08172 1/20 0.36
CHRM4 P08173 1/20 0.36
ADRB1 P08588 1/20 0.36
CYP3A4 P08684 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7551305 0.93 KDR (0.78) KDRFLT1FLT4GSK3BNFATC1
SCHEMBL7976990 0.93 KDR (0.78) KDRFLT1FLT4GSK3BNFATC1
SCHEMBL7548886 0.89 KDR (0.61) KDRFLT1FLT4GSK3BNFATC1
SCHEMBL7554192 0.88 KDR (0.65) KDRFLT1FLT4GSK3BNFATC1
SCHEMBL7555190 0.88 KDR (1.00) KDRFLT1FLT4GSK3BNFATC1
SCHEMBL7545744 0.87 KDR (0.75) KDRFLT1FLT4GSK3BNFATC1
SCHEMBL7556474 0.87 KDR (0.61) KDRFLT1FLT4GSK3BNFATC1
SCHEMBL7551421 0.87 KDR (0.77) KDRFLT1FLT4GSK3BNFATC1
SCHEMBL7550084 0.86 KDR (0.74) KDRFLT1FLT4GSK3BNFATC1
SCHEMBL7977669 0.86 KDR (0.78) KDRFLT1FLT4GSK3BNFATC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1147107-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2002-05-22 EP claimed
EP-1147107-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-10-24 EP claimed
US-6265403-B1 TYROSINE INHIBITORS MERCK & CO., INC. 2001-07-24 US claimed
WO-2000043393-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-07-27 WO claimed
EP-1147107-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2002-05-22 EP disclosed
EP-1147107-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-10-24 EP disclosed
US-6265403-B1 TYROSINE INHIBITORS MERCK & CO., INC. 2001-07-24 US disclosed
WO-2000043393-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-07-27 WO disclosed